Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -16.18% is 51% above its 5-year average of -33.25%, near the high end of its 5-year range (-527.76%–-15.58%).
As of the fiscal period ended Tuesday, June 30, 2026. 27.15% above its 12-month average of -22.22%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -16.18%.
RETURN ON EQUITY (ROE)
-16.18%
RETURN ON EQUITY (ROE) AVG TTM
-22.22%
RETURN ON EQUITY (ROE) AVG 3Y
-25.43%
RETURN ON EQUITY (ROE) AVG 5Y
-33.25%
RETURN ON EQUITY (ROE) AVG 10Y
-64.39%
RETURN ON EQUITY (ROE) AVG 15Y
-37.02%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+27.15%
CURRENT VS 3Y AVG
+36.37%
CURRENT VS 5Y AVG
+51.33%
CURRENT VS 10Y AVG
+74.87%
CURRENT VS 15Y AVG
+56.29%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 650 covered companies
CURRENT VS SECTOR MEDIAN
+59.75%
vs the sector median at left
Standard BioTools Inc.
Market Cap
$288.27M
Return on Equity (ROE)
-16.18%
TTM Avg
-22.22%
3Y Avg
-25.43%
5Y Avg
-33.25%
Market Cap
$287.54M
Return on Equity (ROE)
-49.11%
TTM Avg
-50.02%
3Y Avg
-153.47%
5Y Avg
-149.41%
Market Cap
$288.49M
Return on Equity (ROE)
-56.36%
TTM Avg
-35.98%
3Y Avg
25430.43%
5Y Avg
20391.58%
Market Cap
$288.15M
Return on Equity (ROE)
-18.38%
TTM Avg
-37.53%
3Y Avg
-22.34%
5Y Avg
-10.93%
Market Cap
$285.37M
Return on Equity (ROE)
-135.62%
TTM Avg
-521.17%
3Y Avg
-307.05%
5Y Avg
43.03%
Market Cap
$282.68M
Return on Equity (ROE)
-27.36%
TTM Avg
-12.73%
3Y Avg
-30.52%
5Y Avg
-39.12%
Market Cap
$279.29M
Return on Equity (ROE)
-21.41%
TTM Avg
-11.72%
3Y Avg
-50.56%
5Y Avg
-98.46%
Market Cap
$277.96M
Return on Equity (ROE)
-5.95%
TTM Avg
-61.29%
3Y Avg
-64.14%
5Y Avg
-41.58%
Market Cap
$295.61M
Return on Equity (ROE)
-135.50%
TTM Avg
-129.54%
3Y Avg
-84.04%
5Y Avg
-77.00%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Standard BioTools Inc. (LAB) | $288.27M | -16.18% | -22.22% | -25.43% | -33.25% |
| Abeona Therapeutics Inc. (ABEO)vs › | $287.54M | -49.11% | -50.02% | -153.47% | -149.41% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $288.49M | -56.36% | -35.98% | 25430.43% | 20391.58% |
| Sagimet Biosciences Inc. (SGMT)vs › | $288.15M | -18.38% | -37.53% | -22.34% | -10.93% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.37M | -135.62% | -521.17% | -307.05% | 43.03% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $282.68M | -27.36% | -12.73% | -30.52% | -39.12% |
| Aurora Cannabis Inc. (ACB)vs › | $279.29M | -21.41% | -11.72% | -50.56% | -98.46% |
| SAB Biotherapeutics, Inc. (SABS)vs › | $277.96M | -5.95% | -61.29% | -64.14% | -41.58% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $295.61M | -135.50% | -129.54% | -84.04% | -77.00% |
| Fate Therapeutics, Inc. (FATE)vs › | $275.66M | -82.12% | -62.12% | -56.53% | -50.41% |
ROE
-16.2%
ROA
-13.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -16.18% |
| 2026-03-31 | -16.77% |
| 2025-12-31 | -17.65% |
| 2025-09-30 | -32.09% |
| 2025-06-30 | -28.38% |
| 2025-03-31 | -29.20% |
| 2024-12-31 | -29.44% |
| 2024-09-30 | -25.46% |
| 2024-06-30 | -23.25% |
| 2024-03-31 | -15.58% |
| 2023-12-31 | -45.74% |
| 2022-03-31 | -527.76% |
| 2021-12-31 | -62.62% |
| 2021-09-30 | -68.29% |
| 2021-06-30 | -54.81% |
| 2021-03-31 | -45.44% |
| 2020-12-31 | -38.13% |
| 2020-09-30 | -31.37% |
| 2020-06-30 | -41.11% |
| 2020-03-31 | -39.09% |
| 2019-12-31 | -42.18% |
| 2019-09-30 | -41.13% |
| 2019-06-30 | -39.82% |
| 2019-03-31 | -39.09% |
| 2018-12-31 | -81.83% |
| 2018-09-30 | -244.04% |
| 2018-06-30 | -160.45% |
| 2018-03-31 | -116.48% |
| 2017-12-31 | -195.68% |
| 2017-09-30 | -173.47% |
| 2017-06-30 | -299.21% |
| 2017-03-31 | -190.39% |
| 2016-12-31 | -142.74% |
| 2016-09-30 | -104.70% |
| 2016-06-30 | -71.97% |
| 2016-03-31 | -57.86% |
| 2015-12-31 | -46.40% |
| 2015-09-30 | -41.39% |
| 2015-06-30 | -41.96% |
| 2015-03-31 | -37.45% |
| 2014-12-31 | -35.12% |
| 2014-09-30 | -29.65% |
| 2014-06-30 | -22.44% |
| 2014-03-31 | -16.54% |
| 2013-12-31 | -16.29% |
| 2013-09-30 | -15.96% |
| 2013-06-30 | -15.60% |
| 2013-03-31 | -15.87% |
| 2012-12-31 | -18.90% |
| 2012-09-30 | -18.39% |
| 2012-06-30 | -39.28% |
| 2012-03-31 | -42.05% |
| 2011-12-31 | -39.49% |
| 2011-09-30 | -37.35% |
| 2011-06-30 | -33.68% |
| 2011-03-31 | -27.07% |
